期刊
CURRENT OPINION IN CHEMICAL ENGINEERING
卷 19, 期 -, 页码 1-8出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coche.2017.11.001
关键词
-
Most current vaccine strategies employ live-attenuated or killed versions of the pathogen. While effective in the developed world, expense and cold-chain dependence make broad access to such vaccines difficult in the developing world. Additionally, current vaccine development processes provide only slow responses to emerging or evolved pathogens. Nanoparticle platform technologies for vaccines can overcome these issues. Polymeric nanoparticles have shown pre-clinical success but suffer from structural heterogeneity, instability, and potential off-target immunogenicity issues. Engineered virus-like particles are emerging as a versatile platform for rapid vaccine development. They can be engineered for high stability, facile antigen conjugation in precise orientations, and high potency. Virus-like particle vaccines are poised to deliver the design features required for worldwide distribution of highly effective vaccines.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据